<DOC>
	<DOCNO>NCT01128699</DOCNO>
	<brief_summary>The investigator aim demonstrate efficacy safety subconjunctival injection Avastin adjunctive therapy Ahmed valve glaucoma implant patient refractory glaucoma .</brief_summary>
	<brief_title>Ahmed Valve Glaucoma Implant With Adjunctive Subconjunctival Bevacizumab Refractory Glaucoma</brief_title>
	<detailed_description>Several study reveal evidence substantial role Vascular endothelial growth factor-A ( VEGF-A ) enhance neovascularization process . Some study show efficacy intravitreal Avastin reduce level VEGF-A improve NVG . On hand , recent pathological study demonstrate neutralization VEGF reduce vascularity decrease scar formation wound healing , show VEGF strongly influence scar tissue formation . This may reduce formation encapsulate cyst glaucoma surgery thus might improve surgical success rate . The effect subconjunctival bevacizumab adjunctive therapy filter glaucoma surgery recently illustrate . We aim demonstrate efficacy safety subconjunctival injection Avastin adjunctive therapy Ahmed valve glaucoma implant patient refractory glaucoma .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Clinical diagnosis refractory glaucoma define uncontrolled IOP ( &gt; 21 mm Hg ) despite maximal antiglaucoma medication , previously fail surgical treatment , combination thereof No light perception elevate IOP associate silicone oil previous glaucoma drainage device implantation eye previous cyclodestructive treatment increase risk endophthalmitis ( e.g. , active adnexal ocular surface infection , immunosuppression , immunodeficiency , include use systemic steroid ) posterior segment disorder , preexist ocular comorbidities ( e.g. , pterygium , phacodonesis , corneal opacity , corneal endothelial dystrophy ) . Only 1 eye per patient include trial .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Ahmed valve</keyword>
	<keyword>Neovascular Glaucoma</keyword>
	<keyword>Uveitic glaucoma</keyword>
	<keyword>Failed glaucoma</keyword>
	<keyword>VEGF-A</keyword>
	<keyword>Intraocular pressure</keyword>
	<keyword>Subconjunctival Avastin</keyword>
</DOC>